CIK 0000812796
- Non-accelerated filer
- Smaller reporting company
SOLIGENIX, INC.
Sign in to watch- Ticker
- SNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 411505029
- Phone
- +1 609-538-8200
- Business address
- 29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
- Former names
- SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2007-01-24 | KANZER STEVE H Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2006-05-10 | Brey Robert N Chief Scientific Officer/SrVP | Grant or award · Stock Options (Right to Buy) | +600,000 | 600,000 | ||
| 2006-05-10 | Clavijo James Controller/Treasurer | Grant or award · Stock Options (right to buy) | +200,000 | 200,000 | ||
| 2006-05-10 | MYRIANTHOPOULOS EVAN Chief Financial Officer | Grant or award · Stock Options (right to buy) | +400,000 | 400,000 | ||
| 2006-04-10 | MYRIANTHOPOULOS EVAN Chief Financial Officer | Grant or award | +90,220 | $0.28 | $25K | 90,220 |
| 2006-04-10 | SEMBER MICHAEL T Chief Executive Officer | Grant or award | +180,440 | $0.28 | $50K | 180,440 |
| 2006-04-10 | SEMBER MICHAEL T Chief Executive Officer | Grant or award · Stock Warrants (right to buy) | +180,440 | 180,440 | ||
| 2006-04-10 | MYRIANTHOPOULOS EVAN Chief Financial Officer | Grant or award | +90,220 | $0.28 | $25K | 90,220 |
| 2006-04-10 | MYRIANTHOPOULOS EVAN Chief Financial Officer | Grant or award · Stock Warrants (right to buy) | +90,220 | 90,220 | ||
| 2006-04-10 | SEMBER MICHAEL T Chief Executive Officer | Grant or award | +180,440 | $0.45 | $81K | 180,440 |
| 2006-04-10 | SEMBER MICHAEL T Chief Executive Officer | Grant or award · Stock Warrants (right to buy) | +180,440 | 180,440 | ||
| 2006-01-20 | KANZER STEVE H Director | Exercise or conversion | +250,000 | $0.20 | $50K | 1,069,437 |
| 2006-01-20 | KANZER STEVE H Director | Exercise or conversion · Stock Options (right to buy) | −250,000 | 0 | ||
| 2006-01-10 | Madison T J Director | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2006-01-10 | KUO JAMES S Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2006-01-10 | KANZER STEVE H Director | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2006-01-10 | Haig Alexander P Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2005-02-22 | Clavijo James Controller/Treasurer | Grant or award · Stock Options (right to buy) | +150,000 | 150,000 | ||
| 2004-12-13 | MYRIANTHOPOULOS EVAN Chief Financial Officer | Grant or award · Stock Options (right to buy) | +500,000 | 500,000 | ||
| 2004-12-07 | SEMBER MICHAEL T Chief Executive Officer | Grant or award · Stock Options (right to buy) | +2,000,000 | 2,000,000 |
Page 18 of 22 · 422 trades